Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy

产品简述

期刊

Biomaterials Science


标题

Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy


作者

Shiyang Shen, Meng Liu, Teng Li, Shiqi Lin and Ran Mo


摘要

Combination cancer therapy possesses considerable appeal due to its many merits such as enhancing efficacy by synergistic effects and overcoming drug resistance as compared to monotherapy. Nanomedicine-mediated co-delivery of multiple anticancer agents is more effective than conventional cocktail-based physical mixture of free drugs. A strategy is required to differentiate their unique targets for maximizing the synergistic effects based on individual sites of action of different drugs. This review summarizes the recent progresses in nanomedicine-based combination cancer therapies using site-specific co-delivery strategies, which have been classified by different target sites at the anatomical scales such as tissue, cellular and subcellular levels. In particular, the design of materials and formulations functionalized with tumor-associated signal-responsive elements has been highlighted. The potential and perspective of future developments have also been discussed.


原文链接

http://pubs.rsc.org/en/content/articlelanding/2017/bm/c7bm00297a#!divAbstract

2017年08月09日

添加时间:

FLP reactivity of [Ph3C]+ and (o-tolyl)3P and the capture of a Staudinger reaction intermediate

上一个:

下一个:

Ultra-high loading of sinoporphyrin sodium in ferritin for single-wave motivated photothermal and photodynamic co-therapy
  • 1
本网站由阿里云提供云计算及安全服务